Inspecs Group PLC
LSE:SPEC
Inspecs Group PLC
LSE:SPEC
Price:
73 GBX
4.29%
Updated:
May 9, 2024
Inspecs Group PLC
Cost of Revenue
|
Inspecs Group PLC
Cost of Revenue Peer Comparison
Comparables:
ABDX
CTEC
TSTL
AMS
RUA
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Inspecs Group PLC
LSE:SPEC
|
Cost of Revenue
-£99.7m
|
CAGR 3-Years
-55%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
|
Abingdon Health PLC
LSE:ABDX
|
Cost of Revenue
-£2m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
|
ConvaTec Group PLC
LSE:CTEC
|
Cost of Revenue
$1.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Tristel PLC
LSE:TSTL
|
Cost of Revenue
-£6.9m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-6%
|
|
|
Advanced Medical Solutions Group PLC
LSE:AMS
|
Cost of Revenue
-£56.1m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-8%
|
|
|
Rua Life Sciences PLC
LSE:RUA
|
Cost of Revenue
-£388k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Inspecs Group PLC's Cost of Revenue?
Cost of Revenue
-99.7m
GBP
-99.7m
GBP
Based on the financial report for Dec 31, 2023, Inspecs Group PLC's Cost of Revenue amounts to -99.7m GBP.
What is Inspecs Group PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-26%
-26%
Over the last year, the Cost of Revenue growth was 2%. The average annual Cost of Revenue growth rates for Inspecs Group PLC have been -55% over the past three years , -26% over the past five years .
You don't have any saved screeners yet
